Christopher Bowd1, Linda M Zangwill1, Robert N Weinreb1, Felipe A Medeiros1, Akram Belghith2. 1. Hamilton Glaucoma Center, Department of Ophthalmology and Shiley Eye Institute, University of California, San Diego, La Jolla, California. 2. Hamilton Glaucoma Center, Department of Ophthalmology and Shiley Eye Institute, University of California, San Diego, La Jolla, California. Electronic address: abelghith@ucsd.edu.
Abstract
PURPOSE: "Floor effects" in retinal imaging are defined as the points at which no further structural loss can be detected. We estimated the measurement floors for spectral-domain optical coherence tomography (SDOCT) measurements and compared global change over time in advanced glaucoma eyes. DESIGN: Validity study to investigate measurement floors. METHODS: A longitudinal "Variability group" of 41 eyes with moderate to advanced glaucoma (standard automated perimetry mean deviation ≤-8 dB) was used to estimate measurement floors. Minimum rim width (MRW), ganglion cell-inner plexiform layer thickness (GC-IPLT), and circumpapillary retinal nerve fiber layer thickness (cpRNFLT) were determined. Floors were defined as the average image area with a loss less than first-percentile confidence interval of the variability in this group. Global rate of change and percentage of the region of interest that did not reach the measurement floor at baseline were calculated in 87 eyes with advanced glaucoma (SAP MD ≤-12 dB). RESULTS: Global change over time in longitudinal eyes was -1.51 μm/year for MRW, -0.21 μm/year for GC-IPL, and -0.36 μm/year cpRNFL (all P ≤ .03). The percentage of region of interest that did not reach the floor at baseline was 19% for MRW, 36% for GC-IPLT, and 14% for cpRNFLT. Average (± standard deviation) floors were 105 μm (± 15.9 μm) for MRW, 38 μm (± 3.4 μm) for GC-IPLT, and 38 μm (± 4.2 μm) for cpRNFLT. CONCLUSIONS: In advanced glaucoma, more GC-IPL tissue remains above the measurement floor compared with other measurements, suggesting GC-IPL thickness is the better candidate for detecting progression. Progression in SDOCT measurements is observable in advanced disease.
PURPOSE: "Floor effects" in retinal imaging are defined as the points at which no further structural loss can be detected. We estimated the measurement floors for spectral-domain optical coherence tomography (SDOCT) measurements and compared global change over time in advanced glaucoma eyes. DESIGN: Validity study to investigate measurement floors. METHODS: A longitudinal "Variability group" of 41 eyes with moderate to advanced glaucoma (standard automated perimetry mean deviation ≤-8 dB) was used to estimate measurement floors. Minimum rim width (MRW), ganglion cell-inner plexiform layer thickness (GC-IPLT), and circumpapillary retinal nerve fiber layer thickness (cpRNFLT) were determined. Floors were defined as the average image area with a loss less than first-percentile confidence interval of the variability in this group. Global rate of change and percentage of the region of interest that did not reach the measurement floor at baseline were calculated in 87 eyes with advanced glaucoma (SAP MD ≤-12 dB). RESULTS: Global change over time in longitudinal eyes was -1.51 μm/year for MRW, -0.21 μm/year for GC-IPL, and -0.36 μm/year cpRNFL (all P ≤ .03). The percentage of region of interest that did not reach the floor at baseline was 19% for MRW, 36% for GC-IPLT, and 14% for cpRNFLT. Average (± standard deviation) floors were 105 μm (± 15.9 μm) for MRW, 38 μm (± 3.4 μm) for GC-IPLT, and 38 μm (± 4.2 μm) for cpRNFLT. CONCLUSIONS: In advanced glaucoma, more GC-IPL tissue remains above the measurement floor compared with other measurements, suggesting GC-IPL thickness is the better candidate for detecting progression. Progression in SDOCT measurements is observable in advanced disease.
Authors: Mauro T Leite; Harsha L Rao; Robert N Weinreb; Linda M Zangwill; Christopher Bowd; Pamela A Sample; Ali Tafreshi; Felipe A Medeiros Journal: Am J Ophthalmol Date: 2010-10-20 Impact factor: 5.258
Authors: Donald C Hood; Anastasia Slobodnick; Ali S Raza; Carlos Gustavo de Moraes; Christopher C Teng; Robert Ritch Journal: Invest Ophthalmol Vis Sci Date: 2014-02-03 Impact factor: 4.799
Authors: C E Traverso; J G Walt; S P Kelly; A H Hommer; A M Bron; P Denis; J-P Nordmann; J-P Renard; A Bayer; F Grehn; N Pfeiffer; C Cedrone; S Gandolfi; N Orzalesi; C Nucci; L Rossetti; A Azuara-Blanco; A Bagnis; R Hitchings; J F Salmon; G Bricola; P M Buchholz; S V Kotak; L M Katz; L R Siegartel; J J Doyle Journal: Br J Ophthalmol Date: 2005-10 Impact factor: 4.638
Authors: Jean-Claude Mwanza; Donald L Budenz; Joshua L Warren; Aaron D Webel; Courtney E Reynolds; Diego T Barbosa; Shan Lin Journal: Br J Ophthalmol Date: 2014-12-09 Impact factor: 4.638
Authors: Katie Banister; Charles Boachie; Rupert Bourne; Jonathan Cook; Jennifer M Burr; Craig Ramsay; David Garway-Heath; Joanne Gray; Peter McMeekin; Rodolfo Hernández; Augusto Azuara-Blanco Journal: Ophthalmology Date: 2016-03-23 Impact factor: 12.079
Authors: Akram Belghith; Christopher Bowd; Felipe A Medeiros; Naama Hammel; Zhiyong Yang; Robert N Weinreb; Linda M Zangwill Journal: Invest Ophthalmol Vis Sci Date: 2016-02 Impact factor: 4.799
Authors: Liang Liu; Beth Edmunds; Hana L Takusagawa; Shandiz Tehrani; Lorinna H Lombardi; John C Morrison; Yali Jia; David Huang Journal: Am J Ophthalmol Date: 2019-06-03 Impact factor: 5.258
Authors: Liang Liu; Ou Tan; Eliesa Ing; John C Morrison; Beth Edmunds; Ellen Davis; Seema Gupta; Lorinna H Lombardi; Yali Jia; David Huang Journal: Am J Ophthalmol Date: 2019-11-23 Impact factor: 5.258
Authors: Sasan Moghimi; Christopher Bowd; Linda M Zangwill; Rafaella C Penteado; Kyle Hasenstab; Huiyuan Hou; Elham Ghahari; Patricia Isabel C Manalastas; James Proudfoot; Robert N Weinreb Journal: Ophthalmology Date: 2019-03-08 Impact factor: 12.079
Authors: Seung H Lee; Devon B Joiner; Emmanouil Tsamis; Rashmi Rajshekhar; Eleanor Kim; C Gustavo De Moraes; Robert Ritch; Donald C Hood Journal: Ophthalmol Glaucoma Date: 2019-02-12
Authors: Elham Ghahari; Christopher Bowd; Linda M Zangwill; James Proudfoot; Kyle A Hasenstab; Huiyuan Hou; Rafaella C Penteado; Patricia Isabel C Manalastas; Sasan Moghimi; Takuhei Shoji; Mark Christopher; Adeleh Yarmohammadi; Robert N Weinreb Journal: Am J Ophthalmol Date: 2019-03-14 Impact factor: 5.258